Fusion event
HBV-EYA2 integration
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Integrated sequence
TTTGTAGGCCCACTCACAGTTAATGAGAAAAGAAGATTGCAATTGATTATGCCTGCCAGGTTTTATCCAAAGGTTACCAAATATTTACCATTGGATAAGG| |GTATTAAACCTTATTATCCAGAACATCTAGTTAATCATTACTTCCAAACTAGACACTATTTACACACTCTATGGAAGGCGGGTATATTATATAAGAGAGA
End
45755870/47127231 (Hg38)
miRNAs that regulate target gene
Nearest miRNA
hsa-mir-103a-2/Upstream/1422051; hsa-mir-1-1/Downstream/39736;
Upstream sequence
aCTTAGTGAATTTGTTAACCAGGCCACCAGAAATTCTTCAGAAACACATCTAAAGTGCCACTAACTGTTCTCAACTGAACAGTTAGTTACGGATGAAATT
Downstream sequence
GTTAGTACAAGAATATTTGAAGACAGTCCCCAAATTCCCAAACATCTACCTCTACTTATTATGCAAGTTTCCTTAAGAAAATGCTTATGTggccaagctc
Yang, L., et al. Molecular Characterization of HBV DNA Integration in Patients with Hepatitis and Hepatocellular Carcinoma. J Cancer ,2018,9(18): 3225-3235.